BRIEF-Alnylam Announces Five-Year HELIOS-B Data Demonstrating Sustained Benefit Of AMVUTTRA® (Vutrisiran) In ATTR-CM

2

Nov 9 (Reuters) – Alnylam Pharmaceuticals, Inc. : * ALNYLAM ANNOUNCES FIVE-YEAR HELIOS-B DATA DEMONSTRATING SUSTAINED BENEFIT OF AMVUTTRA® (VUTRISIRAN) IN ATTR-CM * ALNYLAM PHARMACEUTICALS –

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)